A Study Of PF-06647020 For Adult Patients With Advanced Solid Tumors

Study to Evaluate Safety, PK, PD, Immunogenicity & Antitumor Activity of MSC-1 in Patients With Adv Solid Tumors

MGD019 DART® Protein in Unresectable/Metastatic Cancer

A Study Evaluating the Safety, Tolerability, and Initial Efficacy of Recombinant Human Anti-cluster Differentiation Antigen 47 (CD47) Monoclonal Antibody Injection (IBI188) in Patients With Advanced Malignant Tumors and Lymphomas

Study of Selumetinib (MK-5618) in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors (MK-5618-001)

A Study of APX3330 in Patients With Advanced Solid Tumors

PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCL

MGC018 With or Without MGA012 in Advanced Solid Tumors

APG-115 in Patients With Advanced Solid Tumors or Lymphomas

Study of MK-7162 in Combination With Pembrolizumab (MK-3475) in Adult Participants With Advanced Solid Tumors (MK-7162-002)

A Study of ALX148 in Patients With Advanced Solid Tumors and Lymphoma

AVID100 in Advanced Epithelial Carcinomas

A Study of APG-1252 in Patients With SCLC or Other Solid Tumors

Trial of Hu5F9-G4 in Combination With Cetuximab in Patients With Solid Tumors and Advanced Colorectal Cancer

Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Subjects With Locally Advanced or Metastatic Solid Tumors

A Phase 1 Study of INCMGA00012 in Patients With Advanced Solid Tumors

A Trial of Hu5F9-G4 With Avelumab in Ovarian Cancer